In vivo correction of cystic fibrosis mediated by PNA nanoparticles
Author(s) -
Alexandra S. Piotrowski-Daspit,
Christina Barone,
Chun-Yu Lin,
Yanxiang Deng,
Douglas H. Wu,
Thomas C. Binns,
Emily Xu,
Adele S. Ricciardi,
Rachael Putman,
Alannah Garrison,
Ruby H.N. Nguyen,
Anisha Gupta,
Rong Fan,
Peter M. Glazer,
W. Mark Saltzman,
Marie E. Egan
Publication year - 2022
Publication title -
science advances
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.928
H-Index - 146
ISSN - 2375-2548
DOI - 10.1126/sciadv.abo0522
Subject(s) - cystic fibrosis , in vivo , cystic fibrosis transmembrane conductance regulator , electroporation , in vitro , mutation , ex vivo , gene delivery , genetic enhancement , chemistry , microbiology and biotechnology , gene , biology , biochemistry , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom